Gain Therapeutics Overview
Gain Therapeutics Discounted Cash Flow
DCF Analysis for GANX.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.61
Current Fair Value
$0.61
↓ 65.2% Downside
Overvalued by 65.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison